Most Read article list (ranking real-time pageviews since the publication of the article)

Editorial Commentary

What is the role of consolidation immunotherapy after chemoradiotherapy in stage III EGFR-mutant non-small cell lung cancer?

Toyoaki Hida

Published online: 20 October 2023

PDF Full Text (2859) Peer Review File COI Form Open Access

Editorial Commentary

The immune “tsunami” has arrived at the shores of early-stage non-small cell lung cancer

Antonio Rossi, Ettore Mari, Domenico Galetta

Published online: 06 September 2023

PDF Full Text (2633) Peer Review File COI Form Open Access

Editorial Commentary

The Butterfly effect—will the MARIPOSA-2 study alter the trajectory of EGFR mutated non-small cell lung cancer (NSCLC)

Yuji Uehara, Aaron C. Tan

Published online: 06 June 2024

PDF Full Text (756) Peer Review File COI Form Open Access

Editorial Commentary

ADAURA: redefining the role of target therapy in resectable lung adenocarcinoma

Jairo A. Zuluaga, Leonardo Rojas, Oscar Arrieta, Andrés F. Cardona

Published online: 09 April 2024

PDF Full Text (797) Peer Review File COI Form Open Access

Editorial Commentary

The opening gambit: CheckMate 159 and the immunotherapy neoadjuvant era in non-small cell lung cancer

Igor Gómez-Randulfe, Raffaele Califano

Published online: 24 November 2023

PDF Full Text (719) Peer Review File COI Form Open Access

Editorial

Advancing the understanding, reflection, and translation of clinical trials: inaugural editorial to AME Clinical Trials Review

Kaiping Zhang

Published online: 31 May 2023

PDF Full Text (666) COI Form Open Access

1 - 6 of 6 Items